Antibody vaccine conjugates and uses therefor

Details for Australian Patent Application No. 2004213749 (hide)

Owner Celldex Therapeutics, Inc.

Inventors Ramakrishna, Venky; Keler, Tibor; Endres, Michael; He, Lizhen

Agent Shelston IP

Pub. Number AU-B-2004213749

PCT Pub. Number WO2004/074432

Priority 60/443,979 31.01.03 US

Filing date 30 January 2004

Wipo publication date 2 September 2004

Acceptance publication date 25 February 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/59 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/074432 Priority application(s): WO2004/074432

25 February 2010 Application Accepted

  Published as AU-B-2004213749

24 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213752-Methods and compositions for administering therapeutic and diagnostic agents

2004213746-A non-corrosive treatment to enhance pressurized and non-pressurized pulverized coal combustion